Martino Pasquale, Palazzo Silvano, Crudele Vincenzo, Benedetto Giuseppe, Tedeschi Michele, Bettocchi Carlo, Ditonno Pasquale, Lucarelli Giuseppe, Selvaggi Francesco Paolo
Department of Emergency and Organ Transplantation - Urology I, University of Bari "Aldo Moro", Italy.
Arch Ital Urol Androl. 2010 Dec;82(4):284-6.
The simple renal cysts are the most frequent lesions of kidney in adults. Approximately 30% of subjects older than 70 years presents a simple renal cysts. It is well accepted that a simple renal cyst without symptoms does not require any treatment.
Evaluate the efficacy of the echoguided treatment of simple renal cysts with a single sclerotherapy.
Since 1995 to March 2010 in our clinic 329 patients underwent percutaneous drainages of simple renal cysts. In 56 cases (17% of patients) it was a simple aspiration, in 69 cases (21%) a drainage was placed for 24 hour continuous draining and in 204 cases (62%) lesions were treated by sclerotherapy. After aspiration of fluid we injected inside the cyst 99% ethanol in the amount equal to 30% of aspirated volume and never exceeding 60 ml. After 40 minutes we aspirated ethanol and removed the drainage.
The outcome was considered good if the size of the cyst was less of 50% of the primary size. Percutaneous drainage with sclerotherapy showed a success rate of almost 100% using 99% ethanol. However, this method is not completely free from complications.
The long-term results and the mini-invasive modality of treatment without hospedalization are the most important advantages of this procedure. Furthermore our experience showed a good success rate with a single sclerotherapy with benefit to the patient and lower costs of procedure.
单纯性肾囊肿是成人中最常见的肾脏病变。70岁以上的人群中约30%患有单纯性肾囊肿。普遍认为,无症状的单纯性肾囊肿无需任何治疗。
评估超声引导下单次硬化治疗单纯性肾囊肿的疗效。
自1995年至2010年3月,我院329例患者接受了单纯性肾囊肿的经皮引流。56例(占患者的17%)为单纯抽吸,69例(21%)放置引流管进行24小时持续引流,204例(62%)通过硬化治疗。抽出囊液后,向囊内注入99%乙醇,注入量等于抽出液量的30%,且不超过60毫升。40分钟后抽出乙醇并拔除引流管。
如果囊肿大小小于原始大小的50%,则认为治疗效果良好。使用99%乙醇进行硬化治疗的经皮引流成功率几乎为100%。然而,这种方法并非完全没有并发症。
该治疗方法的长期效果以及无需住院的微创治疗方式是其最重要的优点。此外,我们的经验表明单次硬化治疗成功率高,对患者有益且治疗成本较低。